Source: Eur Respir J, 50 (1) 1601651; 10.1183/13993003.01651-2016
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Chandran Nagaraj, Christoph Tabeling, Bence M. Nagy, Pritesh P. Jain, Leigh M. Marsh, Rita Papp, Michael Pienn, Martin Witzenrath, Bahil Ghanim, Walter Klepetko, E. Kenneth Weir, Stefan Heschl, Grazyna Kwapiszewska, Andrea Olschewski, Horst Olschewski. Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox. Eur Respir J, 50 (1) 1601651; 10.1183/13993003.01651-2016

Member's Comments

No comment yet.

Related content which might interest you: Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001 Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension Source: International Congress 2016 – Connective tissue disorders Year: 2016 Perfusion abnormalities related to hypoxic vasoconstriction in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 266s Year: 2002 The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study Source: Eur Respir J 2002; 20: 332-338 Year: 2002 Systemic hypoxia contributes to pulmonary hypertension in heart failure Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Pulmonary vascular involvement in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 28S-32S Year: 2003 Pulmonary hypertensive vasculopathy in parenchymal lung diseases and/or hypoxia Source: Eur Respir Rev, 26 (144) 170003; 10.1183/16000617.0003-2017 Year: 2017 Pulmonary hypertension in chronic lung disease and hypoxia Source: Eur Respir J, 53 (1) 1801914; 10.1183/13993003.01914-2018 Year: 2019 Contrasting exercise cerebral oxigenation in COPD patients with and without chronic heart failure Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases Year: 2013 Gender-related differences in pulmonary hemodynamics in patients with end-stage COPD Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Markers of pulmonary vascular compromise predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Induced acute metabolic acidosis improves alveolar ventilation in chronic hypercapnic COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 517s Year: 2005 Actions of acute and chronic hypoxia on oxygen-sensing pulmonary vascular fibroblasts Source: Annual Congress 2004 - Chronic tissue hypoxia and gene expression: a systems approach to adaptation Year: 2004 Exercise pulmonary haemodynamic response predicts outcomes in fibrotic lung disease Source: Eur Respir J, 52 (3) 1801015; 10.1183/13993003.01015-2018 Year: 2018 Effect of the interaction between hypoxic and hypercapnic chemoreflex activation in the cerebrovascular and cardiovascular function Source: Eur Respir J 2002; 20: Suppl. 38, 408s Year: 2002 Non-invasive ventilation and endothelial function in acute exacerbations of chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration Year: 2019